These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34569948)

  • 1. Using Optical Coherence Tomography to Screen for Cognitive Impairment and Dementia.
    Galvin JE; Kleiman MJ; Walker M
    J Alzheimers Dis; 2021; 84(2):723-736. PubMed ID: 34569948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease.
    Ferrari L; Huang SC; Magnani G; Ambrosi A; Comi G; Leocani L
    J Alzheimers Dis; 2017; 56(3):1101-1107. PubMed ID: 28106555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease.
    Cheung CY; Ong YT; Hilal S; Ikram MK; Low S; Ong YL; Venketasubramanian N; Yap P; Seow D; Chen CL; Wong TY
    J Alzheimers Dis; 2015; 45(1):45-56. PubMed ID: 25428254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Number Symbol Coding Task: A brief measure of executive function to detect dementia and cognitive impairment.
    Galvin JE; Tolea MI; Moore C; Chrisphonte S
    PLoS One; 2020; 15(11):e0242233. PubMed ID: 33253192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Assessment of the Retina Using OCT and Associations with Cognitive Function.
    Ito Y; Sasaki M; Takahashi H; Nozaki S; Matsuguma S; Motomura K; Ui R; Shikimoto R; Kawasaki R; Yuki K; Sawada N; Mimura M; Tsubota K; Tsugane S
    Ophthalmology; 2020 Jan; 127(1):107-118. PubMed ID: 31307828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Resilience Index: A Quantifiable Measure of Brain Health and Risk of Cognitive Impairment and Dementia.
    Galvin JE; Kleiman MJ; Chrisphonte S; Cohen I; Disla S; Galvin CB; Greenfield KK; Moore C; Rawn S; Riccio ML; Rosenfeld A; Simon J; Walker M; Tolea MI
    J Alzheimers Dis; 2021; 84(4):1729-1746. PubMed ID: 34744081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a patient-reported outcome to improve detection of cognitive impairment and dementia: The patient version of the Quick Dementia Rating System (QDRS).
    Galvin JE; Tolea MI; Chrisphonte S
    PLoS One; 2020; 15(10):e0240422. PubMed ID: 33057404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuro-Retina Might Reflect Alzheimer's Disease Stage.
    Santangelo R; Huang SC; Bernasconi MP; Falautano M; Comi G; Magnani G; Leocani L
    J Alzheimers Dis; 2020; 77(4):1455-1468. PubMed ID: 32925026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic Cognitive Screen Technology for Screening Older Adults With Dementia and Mild Cognitive Impairment in a Community Setting: Development and Validation Study.
    Chan JYC; Wong A; Yiu B; Mok H; Lam P; Kwan P; Chan A; Mok VCT; Tsoi KKF; Kwok TCY
    J Med Internet Res; 2020 Dec; 22(12):e17332. PubMed ID: 33337341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-regression framework to improve diagnostic ability of optical coherence tomography retinal biomarkers to discriminate mild cognitive impairment and Alzheimer's disease.
    Chua J; Li C; Ho LKH; Wong D; Tan B; Yao X; Gan A; Schwarzhans F; Garhöfer G; Sng CCA; Hilal S; Venketasubramanian N; Cheung CY; Fischer G; Vass C; Wong TY; Chen CL; Schmetterer L
    Alzheimers Res Ther; 2022 Mar; 14(1):41. PubMed ID: 35272711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical Coherence Tomography in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.
    Mejia-Vergara AJ; Restrepo-Jimenez P; Pelak VS
    Front Neurol; 2020; 11():578698. PubMed ID: 33178120
    [No Abstract]   [Full Text] [Related]  

  • 12. Macular ganglion cell/inner plexiform layer measurements by spectral domain optical coherence tomography for detection of early glaucoma and comparison to retinal nerve fiber layer measurements.
    Nouri-Mahdavi K; Nowroozizadeh S; Nassiri N; Cirineo N; Knipping S; Giaconi J; Caprioli J
    Am J Ophthalmol; 2013 Dec; 156(6):1297-1307.e2. PubMed ID: 24075422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal Microvascular and Neurodegenerative Changes in Alzheimer's Disease and Mild Cognitive Impairment Compared with Control Participants.
    Yoon SP; Grewal DS; Thompson AC; Polascik BW; Dunn C; Burke JR; Fekrat S
    Ophthalmol Retina; 2019 Jun; 3(6):489-499. PubMed ID: 31174670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography in mild cognitive impairment - Systematic review and meta-analysis.
    Noah AM; Almghairbi D; Moppett IK
    Clin Neurol Neurosurg; 2020 Sep; 196():106036. PubMed ID: 32623211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The retinal ganglion cell layer reflects neurodegenerative changes in cognitively unimpaired individuals.
    López-de-Eguileta A; López-García S; Lage C; Pozueta A; García-Martínez M; Kazimierczak M; Bravo M; Irure J; López-Hoyos M; Muñoz-Cacho P; Rodríguez-Perez N; Tordesillas-Gutiérrez D; Goikoetxea A; Nebot C; Rodríguez-Rodríguez E; Casado A; Sánchez-Juan P
    Alzheimers Res Ther; 2022 Apr; 14(1):57. PubMed ID: 35449033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of mild cognitive impairment and early stage dementia with an audio-recorded cognitive scale.
    Sewell MC; Luo X; Neugroschl J; Sano M
    Int Psychogeriatr; 2013 Aug; 25(8):1325-33. PubMed ID: 23635663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer's Disease and Related Disorders.
    Kleiman MJ; Chang LC; Galvin JE
    J Alzheimers Dis; 2022; 90(4):1817-1830. PubMed ID: 36336936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing detection of Alzheimer's disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO.
    Ismail Z; Leon R; Creese B; Ballard C; Robert P; Smith EE
    Mol Neurodegener; 2023 Jul; 18(1):50. PubMed ID: 37516848
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.